INTRODUCTION
Microscopically balanced translocations either can have no phenotypic effect or can cause disease by interrupting the function of protein-coding and noncoding genes or regulatory domains. [1] [2] [3] Recently, next-generation mate-pair sequencing (MPS) has enabled rapid mapping and characterization of chromosomal rearrangements at the base-pair level. 4 Surprisingly, many disease-associated chromosomal rearrangements initially characterized as simple turned out to be more complex than first predicted, revealing a new catastrophic phenomenon of local chromosome shattering termed "chromothripsis" (CTH). [5] [6] [7] [8] [9] [10] CTH was first characterized in cancerous tissue in which up to hundreds of DNA breaks were localized in relatively small genomic regions and the copy-number states oscillated between one and two (and occasionally three). 5, 7 It has been suggested that, in contrast to the progressive model of accumulating mutations in cancer, where rearrangements occur sequentially and independently over many cell cycles, the catastrophic event of CTH happens in a single cell cycle, with profound implications for the etiology of some cancer types. 5 The frequency of CTH is 2-3% in many types of cancer and up to 25% in bone cancers. 5 Soon after its identification in cancer, CTH was also detected in congenital disorders and was termed "germ-line CTH" (G-CTH). 6, [8] [9] [10] Whereas CTH is frequently observed in various human cancers, so far there are data from only a few G-CTH cases. Most of these G-CTH events have been observed in complex chromosomal rearrangements, 6 ,7,9,10 but some have been detected in apparently simple two-way translocations. 8, 9 To date, only four cases of parentally transmitted G-CTH have been reported. In three of the cases, the G-CTH was transmitted in an unbalanced form from a healthy mother, giving rise to congenital malformations and developmental delay in the children. [11] [12] [13] In the fourth case, the G-CTH was also transmitted in
Original research article an unbalanced form from the mother, resulting in the characteristic features of trisomy 9p in a son. 8, 14 However, in this case two other sons inherited the balanced G-CTH, and both boys and the mother had psychomotor developmental delay and major learning difficulties. 8 CTH is suggested to be initiated by extracellular or intracellular genotoxic factors (such as ionizing radiation or reactive oxygen substances) whereby the whole chromosome or a part of it is shattered into multiple pieces, generating DNA double-strand breaks. 5, 9 Cells respond to these breaks through complex repair and signaling mechanisms, collectively termed the DNA damage response (DDR). The early stage of the DDR involves DNA damage recognition by protein complexes containing DNAdependent protein kinase (DNA-PK), ataxia-telangiectasia mutated, and ataxia-telangiectasia and Rad3-related (ATR) protein kinases. 15 ATR and other DDR components are required for delaying cell-cycle progression to enable the repair system to fix the DNA damages, 16 and a defective DDR, including impaired ATR signaling, can ultimately result in genome instability and chromosomal aberrations. 17 Here, we present a new G-CTH affecting two chromosomes and stably segregating in a three-generation family without any apparent association with a disorder. We provide detailed mapping analysis by MPS, describe the affected genes, and speculate that the truncation of one of these genes could be involved in the generation of this familial G-CTH. Furthermore, we describe changes to the extended Human Genome Variation Society (HGVS) sequence variation nomenclature for the standardized description of CTH.
MATeRIALs AND MeTHODs

Cytogenetic analysis
Cytogenetic analyses were carried out as a result of several recurrent miscarriages in the family (Figure 1) .
Karyotyping was performed on G-banded metaphase chromosomes prepared from peripheral blood leukocytes using standard methods.
Next-generation MPs and data analysis
DNA was isolated from the blood leukocytes of the family members I:1, II:6, III:2, and III:14 (Figure 1) . The integrity of genomic DNA was evaluated using agarose gel electrophoresis and the concentration was measured using a Nanodrop ND-1000 spectrometer (ThermoScientific, Waltham, MA). Mate-pair libraries were prepared using Illumina's mate-pair library kit v2 (Illumina, San Diego, CA) for individual II:6, and Nextera mate-pair kit (Illumina) for individuals I:1, III:2, and III:14, following the manufacturer's instructions. For individual II:6, 10 µg of genomic DNA was fragmented and size-selected in the range of 1.5-2.5 kb. The final mate-pair library with sizeselected fragments of 350-650 bp was subjected to 2 × 50 base paired-end sequencing on an Illumina HiSeq2000 sequencing platform. Individuals I:1, III:2, and III:14 were investigated with the gel-free protocol, whereby 1 µg of genomic DNA was fragmented using an enzymatic method generating fragments in the range of 2-15 kb. The final library was subjected to 2 × 100 base paired-end sequencing on an Illumina HiSeq2500 sequencing platform.
Reads passing Illumina quality control were mapped to the human reference genome (GRCh37/hg19) using BurrowsWheeler Aligner. 18 Reads not aligning uniquely were not included, whereas clustered pair-reads with alignment score MAPQ ≥37 were considered for further analysis. The structural variants (SVs), which were indicated by "discordant" mate-pair reads with an unexpected alignment distance and/or orientation, were visualized using the Integrative Genomics Viewer genome browser. 19 In addition, SVDetect 20 was used to annotate the potential SVs and visualize them using the University of California, Santa Cruz (UCSC) Human Genome Browser (http://www.genome.ucsc.edu).
To identify sample-specific SVs, the predicted SVs of these samples were compared with several in-house mate-pair data sets, and rearrangements that were not unique to the present cases were excluded. In addition, the coverage depth of the aligned mate-pair reads was used to detect copy-number changes. The breakpoints (BPs) suggested by MPS were verified using Sanger sequencing.
Chromosome microarray analysis and quantitative PCR (qPCR)
Chromosomal microarray was performed for II:6 using Affymetrix CytoScan HD array (Affymetrix, Santa Clara, CA), and data were analyzed with ChAS software (Affymetrix) using the following filtering criteria: deletions >5 kb (a minimum of 5 markers) and duplications >10 kb (a minimum of 10 markers). Quantitative polymerase chain reaction (qPCR) with Power SYBR Green reagents (Applied Biosystems, Carlsbad, CA) was used to verify relevant structural variations identified in close proximity to the G-CTH BPs. were all karyotyped after identification of several recurrent miscarriages in the family. Individuals III:14 and III:17-III:20 were all screened prenatally for the chromosomal aberration, whereas carrier status of individuals III:2 and III:15 was determined using Sanger sequencing. GTS, Gilles de la Tourette syndrome. 
In silico prediction of fusion genes, transcripts, and proteins
The BP regions were examined using the UCSC Human Genome Browser. Whenever the truncated genes were transcribed in the same orientation, fusion transcripts were further evaluated in silico for presence of open reading frames using the ExPASy Translate tool (http://www.expasy.org).
ResULTs
Family story
The proband (II:6) is a 37-year-old Danish woman initially referred to the Neurogenetics Clinic at the Department of Neurology, Rigshospitalet, with a diagnosis of Gilles de la Tourette syndrome (GTS) (Figure 1) . She is the youngest of three sisters, and cytogenetic analysis was initially performed for one of her sisters (II:2) as a result of several spontaneous miscarriages. Upon identification of an apparently balanced t(3;5)(q25;q31) translocation in II:2, other family members were investigated. The translocation was present in all three sisters (II:2, II:4, II:6) (Supplementary Figure S1 online) and was paternally (I:1) inherited, whereas the mother (I:2) had a normal karyotype. Subsequent cytogenetic analyses performed in the third generation revealed the same translocation in III:14 and III:17-20 (Figure 1) .
II:6 is the only translocation carrier who was diagnosed with GTS, and during counseling she was informed that her mother (I:2) and possibly other maternal relatives also had GTS. However, at the time of the examination, the mother no longer had tics and the other maternal family members were not available for clinical or genetic testing. None of the other clinically examined family members had GTS, although III:19 was suspected to have had tics from the age of 3 years.
I:1 was diagnosed with prostate cancer at the age of 74 years and with polymyalgia rheumatic at the age of 81 years.
II:2 had neonatal pyloric stenosis, which did not require surgical treatment. She had mitral valve insufficiency causing mild dyspnea. From 28 to 36 years of age, she had a total of 12 registered spontaneous miscarriages (III:1, III:3-13) most of which occurred within the first 7-9 weeks of pregnancy.
III:2 also had pyloric stenosis, which was corrected with surgical treatment.
II:4 was diagnosed with multiple pulmonary emboli at the age of 35 years. She had a single spontaneous abortion.
Written informed consent was obtained from all the included individuals. No other family members were available for examination.
Characterization of the breakpoints
The initial MPS of II:6 revealed that the chromosome rearrangement was more complex than first expected because six structural rearrangements involving chromosomes 3 and 5 were detected (Figure 2a, Supplementary Table S1 online). An ~6.4-Mb region of chromosome 3q22.3-q23 was shattered by six BPs, generating seven fragments (3a-3g), whereas chromosome 5 had a single BP. In addition, an ~109-kb deletion on 3q22.3 (fragment 3c) was detected by a decrease in coverage of mate-pair reads and verified by chromosome microarray. Therefore, we renamed this apparently balanced translocation as a G-CTH and constructed a model (Figure 2 ) that was subsequently validated by Sanger sequencing. We also investigated four translocation carriers for whom DNA was available (I:1, II:2, II:4, and III:14) and two family members who were not previously karyotyped using Sanger sequencing (III:2 and III:15). In all six individuals we detected the same BPs and all the BPJ sequences were identical. Subsequent MPS of individuals I:1, III:2, and III:14 confirmed that the G-CTH was stably segregating in three generations and that no additional rearrangements had occurred from one generation to the next (Supplementary Table S1 online). Sequences spanning the BPJs obtained from Sanger sequencing are submitted for each of the investigated individuals to GenBank (http://www.ncbi.nlm.nih.gov/genbank/) with accession numbers KP083371-KP083409.
Six protein coding (UCSC RefSeq) genes were truncated by the G-CTH BPs: PPP2R3A (protein phosphatase 2, regulatory subunit B, α), CLDN18 (claudin 18), A4GNT (α-1,4-Nacetylglucosaminyltransferase), DBR1 (debranching RNA lariats 1), HSD17B4 (hydroxysteroid 17-β dehydrogenase 4), and ATR (Figure 2a) . Furthermore, the deleted fragment (3c) contained the entire DZIP1L (DAZ interacting zinc finger protein 1-like) gene, as well as the 3ʹ-ends of the flanking genes CLDN18 (exons 2-5) and A4GNT (exon 3). The truncated genes were in the same orientation in only two BPJs (4 and 5), and they are predicted to result in two fusion genes (between CLDN18-HSD17B4 and HSD17B4-DBR1, respectively) with several alternative transcripts potentially coding for small truncated fusion proteins (Figure 2, Table 1, Supplementary  Figure S2 online).
Nomenclature
We describe the G-CTH according to the ISCN-2013 (International System for Human Cytogenetic Nomenclature) 21 recommendations as: 46,XX,t(3;5)(q22.3;q23.1).arr[GRCh37] 3q23.3(137735950-137845369)x1.ngs 3q22.3q23(135827611-142218722)cth. Similar to the arr nomenclature, we suggest using the symbol ngs to indicate that the G-CTH was detected with next-generation sequencing and not with karyotyping or array.
However, description of CTH on the sequence level is much more challenging. Recently, simple translocations were described by extending the HGVS sequence variation nomenclature (see http://www.hgvs.org/mutnomen/SVtrans_HGVS2013_PT.pdf for details). This extension supports combination of rearrangements with simple sequence variants without introducing ambiguity and allowing complete reconstruction of breakpoint sequences. There are current publications regarding the issue, 22 but descriptions of structural rearrangements at both the cytogenetic and sequence levels are currently being discussed by ISCN and HGVS committees. In line with the latest view of the HGVS committee, we propose some changes to its original extended description and apply it to G-CTH. We suggest describing the Original research article derivative chromosomes (to which the centromere belongs to) starting from the intact terminus (ter), pter or qter. A given derivative chromosome can thus be described as an intact strand starting from a terminus using the positions of the chromosomal BPJs of the segments composing it and ending with another terminus. Because all segments can be indicated as ranges, these can be followed by inv (inversions), del (deletions), or dup (duplications). Consecutive ranges from the same chromosome can be put between square brackets [ ] to avoid repetition of the chromosome number. The human genome assembly version (e.g., hg19 or GRCh37/hg19) can also be indicated at the start of the HGVS component. The double-colon symbol :: can be used to indicate the translocation as well as the CTH BPs. The HGVS description of the derivative chromosomes 3 and 5 is as follows: The effects of the BPs at both the gene and protein levels are shown in Table 1 .
DIsCUssION
In this study, we describe and characterize familial G-CTH involving chromosomes 3 and 5 that stably segregates in three generations. MPS analyses of four family members from three generations (I:1, II:6, III:2, and III:14) revealed that six out of seven BPs were localized within an ~6.4-Mb region on 3q22.3-3q23, resembling a "shattering" phenomenon The six breakpoints on the q arm of the chromosome 3 shattered the chromosome into seven fragments (3a-3g), whereas the q arm of chromosome 5 was only divided into two fragments (5a and 5b). The genomic coordinates for each shattered fragment show the exact positions of the junction sequences found by Sanger sequencing. There are six truncated protein coding genes at the breakpoints, whereas DZIP1L is completely deleted due to the deleted fragment 3c. The horizontal arrows underlying the gene names indicate the transcription orientation of the genes. The curved arrows show the rearrangements and numbering of arrows (1-6) corresponds to the breakpoint junctions used in supplementary Table s1 online. (b) The derivative chromosomes as determined by mate-pair sequencing, chromosome microarray, and Sanger sequencing. The derivative chromosome 3 consists of the 3a fragment joined together with an inverted 3e fragment, followed by the 3f, 3b, and 5b fragments, which were all in the same orientation as the 3a fragment. The derivative chromosome 5 consists of the 5a fragment joined together with an inverted 3d fragment, followed by an uninverted 3g fragment. The 3c fragment was lost after the chromosome shattering. The horizontal arrows underlining the fragments show the orientation of the fragment in the derivative chromosome with respect to their orientation on the normal chromosomes. The small horizontal arrows underlining the truncated genes at the breakpoint junctions indicate the potential transcription orientation. The breakpoint junctions are numbered 1 to 6, accordingly. (Figure 1) . This is the first report of G-CTH stably segregating through three generations, where each of the 11 family members carries the rearrangement.
The present family was referred to genetic counseling due to numerous recurrent miscarriages, which are likely to result from unbalanced transmission of the G-CTH. The GTS observed in this family cannot readily be related to the translocation because I:2 with GTS earlier in life is not a translocation carrier and because the other translocation carriers (except for II:6) do not have GTS (Figure 1) . The clinical findings of potential importance with regard to the G-CTH may be pyloric stenosis in two family members (II:2, III:2) and prostate cancer in a single family member (I:1). Of the seven protein-coding genes affected, five are not likely to be associated with any of these phenotypes. DZIP1L, which is entirely deleted, encodes a zinc finger protein involved in ciliogenesis. 23 HSD17B4 encodes an enzyme involved in peroxisomal fatty acid oxidation, and homozygous or compound heterozygous mutations result in D-bifunctional protein deficiency, a severe autosomal recessive disorder that leads to death in early childhood in the majority of cases.
24 DBR1 encodes an enzyme that plays a key role in the intron-degrading pathway following pre-mRNA splicing.
25
DBR1 has been suggested as a therapeutic target for both amyotrophic lateral sclerosis 26 and HIV, 27 but DBR1 mutations are not related to any disorder. CLDN18 encodes an integral membrane protein that forms tight junctions in lung and stomach epithelial cells, 28 whereas PPP2R3A encodes a regulatory subunit of protein phosphatase 2A, a candidate tumor suppressor implicated in various cancer types. 29 Truncation of two other genes, however, may potentially be associated with some of the symptoms of the G-CTH carriers. A4GNT encodes a transferase expressed in gastric mucosa, where it plays a protective role against Helicobacter pylori infections, which are normally associated with gastric cancer. 30 Animal studies have shown that A4gnt knock-out mice develop gastric cancer due to abnormal proliferation of pyloric epithelial cells in the gastric antrum, 31 but whether truncation of a single A4GNT allele could result in abnormal proliferation of pyloric epithelial cells in humans is unknown. It is notable that II:2 and her son (III:3) were both diagnosed with pyloric stenosis in early childhood. However, because pyloric stenosis is not reported in the other G-CTH carriers, it is currently unknown whether haploinsufficiency of A4GNT could be directly associated with this feature, and presence of other yet unknown contributing genetic or environmental factor cannot be excluded.
Homozygous and compound heterozygous mutations of ATR are associated with Seckel syndrome, which is characterized by intrauterine growth restriction, microcephaly, intellectual disability, and dwarfism, 32, 33 features that are not present in any of the members of the present family. A heterozygous ATR missense mutation was shown to segregate with oropharyngeal cancer and skin telangiectasia in a five-generation family, 34 and Atr +/-mice exhibit an increased incidence of benign tumors. 35 However, truncation of the gene is not likely to be associated with cancer in the present family because only the grandfather (I:1) has developed prostate cancer, which is relatively common in elderly men.
It can be speculated that truncation of ATR may be associated with the G-CTH formation in this family. ATR encodes one of the major regulators of the DDR, 36 and an impaired DDR has been hypothesized as a cause of CTH formation. 37 Supporting this notion, cells obtained from Seckel syndrome patients exhibit increased micronucleus formation and DNA damage-induced nuclear fragmentation, together with elevated genomic instability, 38 all of which are characteristics that have been related to the catastrophic events leading to CTH. 39 It is Original research article thus possible that the truncation of the ATR gene has been the initiating event in a previous generation, but further evidence is necessary to support this hypothesis.
It is notable that all the offspring of the G-CTH carriers in this family are also carriers of the G-CTH. Thus, no one carries two normal chromosomes 3 and 5, as would be expected. It is therefore possible that the G-CTH confers a proliferative advantage to the germ-line cells carrying this rearrangement compared to cells without it. Because ATR regulates cell cycle checkpoints, 35 reduced ATR levels due to truncation may result in less strict control of DNA replication and earlier entry into mitosis leading to increased cellular proliferation.
The stable segregation of the G-CTH rearrangement through three generations in the present family provides further insight into the catastrophic event of CTH formation. In cancer, the progressive and multistep acquisition of extensive genomic mutations is the classical model for carcinogenesis, but whether this is also valid for CTH is being questioned. 40 Several features of CTH suggest that multiple rearrangements occur within a short period of time or even within a single cell cycle. 5 Inherited G-CTH cases can thus provide valuable information for tracing the progression of the rearrangements over several generations. Therefore, the stable segregation of G-CTH through three generations in 11 members of the present family demonstrates that once CTH is formed and repaired, it can be stable and does not necessarily progress any further, thus supporting the "single event" hypothesis for CTH. This finding is in line with other cases of transmitted G-CTH where no de novo breaks occur in the children. 13 However, characterization of additional familial cases of G-CTH is necessary to confirm this hypothesis.
In conclusion, our study demonstrates the importance of applying MPS to detect and delineate complex rearrangements, such as G-CTH, at the base-pair level, providing a better understanding of the mechanisms involved in G-CTH formation. We show that G-CTH may stably segregate in several generations, supporting the single-event hypothesis for CTH. Furthermore, our study illustrates that G-CTH may not always be associated with an abnormal phenotype, suggesting that the prevalence of G-CTH may be higher than currently recognized. Finally, we attempt to apply the HGVS nomenclature to describe complex structural variants involved in CTH.
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